3 terminated, 1 completed. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Terminated 3, Completed 1 |
Follow Danielle Kim Turgeon: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 1 In-vivo Biliary Study of KSP/QRH Heptapeptide Dimer KSP/QRH dimer - Cholangiocarcinoma | Phase 1 | Terminated | Danielle Kim Turgeon | 12 | 2020-09-22 | 2022-11-22 |
| Gastric Gluten-Degradation Activity of PvP001 Low-dose PvP001, Medium-dose PvP001, High-dose PvP001 - Digestive System Disease | Phase 1 | Terminated | Danielle Kim Turgeon | 43 | 2018-05-25 | 2019-02-15 |
| Study of QRH-882260 Heptapeptide Application in the Colon QRH-882260 Heptapeptide, Scanning Fiber Endoscope - Colon Cancer Prevention | Phase 1 | Terminated | Danielle Kim Turgeon | 5 | 2017-03-31 | 2018-04-24 |
| Study of KCC Peptide Application in the Colon Colon KCC Heptapeptide - Colon Polyps, Colorectal Cancer | Phase 1 | Completed | Danielle Kim Turgeon | 45 | 2014-06-01 | 2017-04-04 |
Cholangiocarcinoma (1) · Colonic Polyps (1) · Colorectal Neoplasms (1) · Digestive System Diseases (1) · Inflammatory Bowel Diseases (1)
United States (4)
D K Turgeon, MD (1)